Groups | Dose (mg/kg) | Growth of weight (g) | Organ indices (mg/g) | |||||
---|---|---|---|---|---|---|---|---|
Spleen | Thymus | Heart | Liver | Lung | Kidney | |||
S180 tumor model | ||||||||
Control | - | 4.08 ± 0.61 | 7.02 ± 0.70 | 2.24 ± 0.22 | 5.17 ± 0.40 | 63.71 ± 3.53 | 6.88 ± 0.52 | 13.01 ± 0.61 |
TAFU | 20 | 2.36 ± 0.81### | 6.86 ± 0.20## | 2.43 ± 0.35## | 4.34 ± 0.12 | 63.28 ± 2.10# | 7.29 ± 0.37 | 13.00 ± 0.50 |
 | 40 | 2.84 ± 0.74# | 6.67 ± 0.17## | 1.98 ± 0.12*, # | 4.67 ± 0.20 | 56.04 ± 1.11* | 6.62 ± 0.21 | 12.29 ± 0.37 |
 | 80 | 2.45 ± 0.50## | 5.43 ± 0.11*, # | 1.84 ± 0.17* | 4.55 ± 0.30 | 58.50 ± 0.82 | 6.39 ± 0.45 | 12.88 ± 0.63 |
CTX | 20 | −1.82 ± 0.64*** | 4.26 ± 0.16*** | 1.30 ± 0.15** | 4.73 ± 0.18 | 52.72 ± 3.30* | 6.75 ± 0.39 | 12.81 ± 0.59 |
LLC tumor model | ||||||||
Control | - | 0.64 ± 0.48 | 6.07 ± 0.91 | 1.57 ± 0.32 | 5.93 ± 0.48 | 57.54 ± 3.99 | 6.90 ± 0.52 | 13.63 ± 0.60 |
TAFU | 20 | 0.58 ± 0.68### | 7.74 ± 0.57## | 1.25 ± 0.13### | 5.22 ± 0.32# | 58.69 ± 1.32# | 7.20 ± 0.33* | 12.54 ± 0.55 |
 | 40 | 0.37 ± 0.32*, ## | 7.53 ± 0.38## | 1.18 ± 0.04## | 5.25 ± 0.43# | 53.44 ± 1.20# | 7.33 ± 0.10 | 11.17 ± 0.22 |
 | 80 | 0.29 ± 0.50*, ## | 5.68 ± 0.82# | 1.09 ± 0.07*, ## | 4.86 ± 0.12* | 53.85 ± 4.96# | 6.87 ± 0.60# | 11.69 ± 0.40 |
CTX | 20 | −1.88 ± 0.71*** | 4.05 ± 0.42** | 0.41 ± 0.05*** | 4.38 ± 0.17* | 44.34 ± 3.59* | 6.80 ± 0.54 | 11.96 ± 0.62 |